. 2020 Oct 14;93(3):1792–1795. doi: 10.1002/jmv.26554

Table 1.

Inactivation of SARS‐CoV‐2 and HCoV‐229E by ColdZyme® (CZ‐MD)

Virus	Sample	Input load log₁₀TCID50 (mean)^a	Output load log₁₀TCID50 (mean ± SD)	log₁₀ Reduction (mean)	Percent inactivation
SARS‐CoV‐2, strain USA‐WA1/2020, BEI Resources NR‐52281	CZ‐MD	6.06	4.30 ± 0.21	1.76	98.3
SARS‐CoV‐2, strain USA‐WA1/2020, BEI Resources NR‐52281	Reference agent (2000 ppm NaOCl)		≤ 1.61	≥4.45
Human coronavirus (HCoV), strain 229E, ATCC VR‐740	CZ‐MD	5.55	2.67 ± 0.13	2.88	99.9
Human coronavirus (HCoV), strain 229E, ATCC VR‐740	Reference agent (2000 ppm NaOCl)		≤1.31	≥4.24

Abbreviation: SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; TCID50, 50% tissue culture infectious dose.

Mean of two experimental values.